Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00436904
Status:
COMPLETED
Last Update Posted:
2011-12-01
First Post:
2007-02-15
Brief Title:
Alemtuzumab and Rituximab in Treating Patients With High-Risk Early-Stage Chronic Lymphocytic Leukemia
Sponsor:
Organization:
Mayo Clinic